KolmarBNH Co Ltd
KOSDAQ:200130
KolmarBNH Co Ltd
Cost of Revenue
KolmarBNH Co Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
K
|
KolmarBNH Co Ltd
KOSDAQ:200130
|
Cost of Revenue
-₩530.6B
|
CAGR 3-Years
-5%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
AmorePacific Corp
KRX:090430
|
Cost of Revenue
-₩1.1T
|
CAGR 3-Years
6%
|
CAGR 5-Years
5%
|
CAGR 10-Years
-1%
|
|
|
Amorepacific Group
KRX:002790
|
Cost of Revenue
-₩1.2T
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
1%
|
|
|
Cosmax Inc
KRX:192820
|
Cost of Revenue
-₩1.7T
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-9%
|
CAGR 10-Years
N/A
|
|
|
LG H&H Co Ltd
KRX:051900
|
Cost of Revenue
-₩3.3T
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
-4%
|
|
|
Kolmar Korea Co Ltd
KRX:161890
|
Cost of Revenue
-₩1.8T
|
CAGR 3-Years
-15%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
-17%
|
|
KolmarBNH Co Ltd
Glance View
KolmarBNH Co., Ltd. engages in the provision of manufacturing medicaments. The company is headquartered in Sejong, Sejong. The company went IPO on 2014-07-23. The firm mainly produces health functional foods to improve immunity, such as atomy hemohims and others. The firm also produces cosmetics using natural extracts, and other pharmaceuticals. The firm also engages in research, development and manufacture of cosmetic functional materials which belongs to phytochemical business that mainly uses natural extracts as cosmetic materials.
See Also
What is KolmarBNH Co Ltd's Cost of Revenue?
Cost of Revenue
-530.6B
KRW
Based on the financial report for Dec 31, 2024, KolmarBNH Co Ltd's Cost of Revenue amounts to -530.6B KRW.
What is KolmarBNH Co Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-9%
Over the last year, the Cost of Revenue growth was -6%. The average annual Cost of Revenue growth rates for KolmarBNH Co Ltd have been -5% over the past three years , -9% over the past five years .
You don't have any saved screeners yet